Adamas to present at upcoming h.c. wainwright conference

Emeryville, calif., jan. 04, 2021 (globe newswire) -- adamas pharmaceuticals, inc. (nasdaq: adms), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that neil f. mcfarlane, the company's chief executive officer, will participate in a fireside chat at the h.c. wainwright virtual bioconnect conference, being held january 11 – 14, 2021.
ADMS Ratings Summary
ADMS Quant Ranking